advert
advert
Angel News

Back to Homepage

12th September 2018 - 0 comments

JOB TODAY announces UK growth and secures $16M to fill Brexit gap

 

JOB TODAY, the UK’s number one mobile hiring app, today announces that it has raised a further $16M to fill the Brexit gap with young job seekers, as EU workers leave their jobs and the country.

 

12th September 2018 - 0 comments

Fine, or not so much?  AngelNews Wine Column

Fine, adjective - Of very high quality; very good of its kind.

Fine, adjective - Good; satisfactory.

Wine - An alcoholic drink made from fermented grape juice.

That’s cleared that up, then.

11th September 2018 - 0 comments

Crowdcube acquires business reporting product Supdate

Crowdcube, the world’s first and largest equity crowdfunding platform, is delighted to announce the acquisition of the business reporting software company Supdate. Through this new product, Crowdcube funded companies will be more connected with their shareholders than ever.

This acquisition advances Crowdcube’s strategy of developing an ecosystem of services for entrepreneurs and investors using its platform. This new product will add to the existing suite of post-funding benefits available to businesses on Crowdcube, such as access to Amazon’s Launchpad Programme, to allow them to fully benefit from their crowdfunded raise. 

11th September 2018 - 0 comments

Arecor raises £6m for revolutionary diabetes treatments

Arecor, the UK-based biopharmaceutical formulation company, has raised £6 million from new and existing investors to develop groundbreaking pharmaceutical drugs to transform the treatment of diabetes. The fundraising was led by Calculus Capital, Albion Capital, and Downing Ventures.  BioScience Managers Limited, the international healthcare investment firm, advised Downing Ventures.

Through the application of its technology platform, Arecor is creating faster working, more effective drugs that help progress the creation of the next generation of artificial pancreas systems. The Company’s ultra-rapid acting insulin and ultra-concentrated insulins more closely mimic the insulin profile and response to glucose of healthy individuals, improving health outcomes and quality of life for people living with diabetes while reducing the wider costs to health services and society.

11th September 2018 - 0 comments

Resonance Health & Wellbeing Challenge Fund supports suicide charity

A Devon based social enterprise Action To Prevent Suicide CIC, is the fifth organisation to receive a £10,000 launchpad loan from the Health & Wellbeing Challenge Fund (South West) (H&WCF), managed by social investment company Resonance. The £10K unsecured loan will allow the enterprise to build capacity, take on further staff and increase their order book, enabling them to draw further investment from the Fund in the future.

11th September 2018 - 0 comments

Cambridge spinout AudioTelligence raises £3.1 million

Cambridge start-up AudioTelligence has developed the world’s first digital solution to the problem. The company has raised £3.1million from Cambridge Innovation Capital and Cambridge Enterprise to grow its team to meet the considerable demand for its technology, which, in addition to helping humans to hear and understand speakers in the presence of loud background noise, helps to improve the performance of voice recognition systems.

AudioTelligence CEO Ken Roberts explains that one of the major motivations in developing the technology was to overcome the ‘cocktail party problem’. This is a particular area of interest to Professor Peter Rayner who founded the Signal Processing and Communications Laboratory at the University of Cambridge.

11th September 2018 - 0 comments

CupClub raises £200k from Henley Business Angels

CupClub, a returnable packaging service for drinks centred on the reduction of single use plastics, has received investment from a Henley Business Angels member, raising a total of £200k from their seed round.

CupClub’s packaging as a service is designed to hold both hot or cold drinks serving initially across offices, universities and closed campuses across cafés and canteens, self-service coffee/tea points and drinks vending. The service uses half the amount of carbon dioxide compared with ceramic or disposable cups (e.g. paper, Styrofoam or compostable).

10th September 2018 - 0 comments

MyLife Digital secures further funding from BGF

UK-based privacy technology and data analytics company MyLife Digital has completed a new c.£6million funding round to support the international roll out of its innovative platform.  BGF has added £3 million of funding to its initial £2 million investment made in 2016, alongside a £2.7 million venture debt facility from Barclays to support MyLife Digital’s growth ambitions.

10th September 2018 - 0 comments

Stephen Critchlow named regional Barclays Icon of the Year Award

Manchester based CEO of Evergreen Group, Stephen Critchlow, has been recognised for his contribution to sustainable business growth in the North region, in the Barclays Entrepeneur Awards 2018.

10th September 2018 - 0 comments

Index Ventures tops list of most active UK VCs

Index Ventures tops Beauhurst's table of the UK's most active VC funds.

10th September 2018 - 0 comments

Resonance backs Jericho Foundation with 100,000 SITR investment

A leading Birmingham enterprise is celebrating after securing £100,000 of SITR (Social Investment Tax Relief) investment from social investment company Resonance to help it expand its ‘upcycling’ venture.

This is the first investment from the Resonance West Midlands SITR Fund, launched earlier this year with £1.25m initial investment dedicated to providing affordable finance to social enterprises committed to dismantling poverty in the region.

10th September 2018 - 0 comments

NVM leads a £3.2 million investment in Ridge Pharma

NVM has invested £2.75 million of growth capital (with the balance of the £3.2m funding round provided by existing investors and private individuals) into Reading-based pharmaceutical company Ridge Pharma Limited (“Ridge”)Ridge is an emerging UK pharmaceutical business set to commercialise their first product in late 2018, with further launches thereafter.   Ridge was founded on the belief that consistently offering medicines with distinct benefits and clear value is at the heart of a rewarding and sustainable business.

PREVIOUSItems 5784 of 7589NEXT

Back to Homepage